Related Experiment Video
Updated: Jul 3, 2026

An Open-Source Framework for Mass Calculation of Antibody-Based Therapeutic Molecules
Published on: June 16, 2023
OECD guidelines on open access: commercialization in disguise?
Klaus Hoeyer1, Mette N Svendsen, Lene Koch
1Department of Health Services Research, Institute of Public Health, University of Copenhagen, Øster Farimagsgade 5, Building 15, DK-1014 Copenhagen K, Denmark. k.hoeyer@pubhealth.ku.dk
Abstract:
The Organisation for Economic Co-operation and Development (OECD) has published a new set of principles and guidelines to promote open access to datasets and results from publicly funded research. However, there is reason to think twice about the implications of making demands for transparency and open access for publicly funded research only. How will such demands affect incentives and research agendas? Might this new regulation of publicly funded research have undesirable effects on the quality and value of research? Placing the OECD guidelines in a broader context of research regulation, we argue that they might provide a further push toward collaboration with commercially sponsored research and reinforce incentive structures that favour the creation of commercial value.
Related Concept Videos
Legal Guidelines for Documentation
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast, controlled...
Prescription, Nonprescription and Orphan Drugs
The misuse and addiction to prescription drugs is a growing problem that can affect people of all age groups, specifically teenagers. This can happen when prescription medications are used in ways not intended by the prescriber, such as taking someone else's prescription or using medication for...
Bioequivalence: Overview
Sustainable Development
Free Energy
